A better COVID treatment for the immunocompromised?

A combination of two antiviral compounds may be a promising alternative to Paxlovid when treating COVID-19 in immunocompromised patients, Yale researchers find.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news